A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The "striking" findings showed an ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL ...

Learn how prostate cancer is treated at each stage, from active surveillance and surgery to radiation, hormone therapy, and targeted drugs.

When I tell a patient he has prostate cancer, this is usually what he asks me first. With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — ...

With active surveillance, the care team closely watches the cancer rather than starting treatment. This can include PSA testing every six months to a year, periodic prostate MRIs and repeat biopsies.